Evolving value and validity of animal models in veterinary therapeutic research: Impact of scientific progress
In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific...
Saved in:
| Published in | European journal of pharmaceutical sciences Vol. 210; p. 107111 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.07.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0928-0987 1879-0720 1879-0720 |
| DOI | 10.1016/j.ejps.2025.107111 |
Cover
| Abstract | In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific evidence, evolving standards in animal welfare, and the development of alternative methodologies. Such a reassessment is essential for maintaining ethical scientific practices and ensuring that research approaches remain both relevant and justifiable, especially as our awareness of animal pain, sentience, and consciousness deepens. While interspecies extrapolation of findings from these models poses challenges when applied to human medicine, what about cases where an animal species serves as both the experimental subject and the intended veterinary patient? Additionally, what alternative tools are potentially available to replace in vivo studies in these contexts? This commentary explores how veterinary research may improve efforts to meet the principles of the 3R’s by integrating alternative in vitro and in silico models early in the investigative process and utilizing specialized tools within the target veterinary population during clinical trials.
[Display omitted] |
|---|---|
| AbstractList | In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific evidence, evolving standards in animal welfare, and the development of alternative methodologies. Such a reassessment is essential for maintaining ethical scientific practices and ensuring that research approaches remain both relevant and justifiable, especially as our awareness of animal pain, sentience, and consciousness deepens. While interspecies extrapolation of findings from these models poses challenges when applied to human medicine, what about cases where an animal species serves as both the experimental subject and the intended veterinary patient? Additionally, what alternative tools are potentially available to replace in vivo studies in these contexts? This commentary explores how veterinary research may improve efforts to meet the principles of the 3R’s by integrating alternative in vitro and in silico models early in the investigative process and utilizing specialized tools within the target veterinary population during clinical trials.
[Display omitted] In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific evidence, evolving standards in animal welfare, and the development of alternative methodologies. Such a reassessment is essential for maintaining ethical scientific practices and ensuring that research approaches remain both relevant and justifiable, especially as our awareness of animal pain, sentience, and consciousness deepens. While interspecies extrapolation of findings from these models poses challenges when applied to human medicine, what about cases where an animal species serves as both the experimental subject and the intended veterinary patient? Additionally, what alternative tools are potentially available to replace in vivo studies in these contexts? This commentary explores how veterinary research may improve efforts to meet the principles of the 3R's by integrating alternative in vitro and in silico models early in the investigative process and utilizing specialized tools within the target veterinary population during clinical trials. In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific evidence, evolving standards in animal welfare, and the development of alternative methodologies. Such a reassessment is essential for maintaining ethical scientific practices and ensuring that research approaches remain both relevant and justifiable, especially as our awareness of animal pain, sentience, and consciousness deepens. While interspecies extrapolation of findings from these models poses challenges when applied to human medicine, what about cases where an animal species serves as both the experimental subject and the intended veterinary patient? Additionally, what alternative tools are potentially available to replace in vivo studies in these contexts? This commentary explores how veterinary research may improve efforts to meet the principles of the 3R's by integrating alternative in vitro and in silico models early in the investigative process and utilizing specialized tools within the target veterinary population during clinical trials.In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the safety and efficacy of potential therapies. However, the value and validity of these models warrants reassessment in light of emerging scientific evidence, evolving standards in animal welfare, and the development of alternative methodologies. Such a reassessment is essential for maintaining ethical scientific practices and ensuring that research approaches remain both relevant and justifiable, especially as our awareness of animal pain, sentience, and consciousness deepens. While interspecies extrapolation of findings from these models poses challenges when applied to human medicine, what about cases where an animal species serves as both the experimental subject and the intended veterinary patient? Additionally, what alternative tools are potentially available to replace in vivo studies in these contexts? This commentary explores how veterinary research may improve efforts to meet the principles of the 3R's by integrating alternative in vitro and in silico models early in the investigative process and utilizing specialized tools within the target veterinary population during clinical trials. |
| ArticleNumber | 107111 |
| Author | Toutain, Pierre-Louis Martinez, Marilyn N. Mochel, Jonathan P. |
| Author_xml | – sequence: 1 givenname: Marilyn N. surname: Martinez fullname: Martinez, Marilyn N. email: marilyn.martinez@fda.hhs.gov organization: Center for Veterinary Medicine, US Food and Drug Administration, Rockville, MD, USA – sequence: 2 givenname: Jonathan P. orcidid: 0000-0002-0997-3111 surname: Mochel fullname: Mochel, Jonathan P. email: jpmochel@uga.edu organization: Precision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 501 DW. Brooks Drive, Athens, GA 30602, USA – sequence: 3 givenname: Pierre-Louis surname: Toutain fullname: Toutain, Pierre-Louis organization: Department of Comparative Biomedical Sciences, The Royal Veterinary College, University of London, London, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40286991$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUFv3CAQhVGVqNmk_QM9VBx78QaMDabqpYrSJlKkXJIzwjAkrGzsAra0_764m_bYEwPzvUHz3iU6C1MAhD5RsqeE8uvDHg5z2tekbsuDoJS-QzvaCVkRUZMztCOy7ioiO3GBLlM6EEJ4J8h7dNGQuuNS0h0Kt-s0rD684FUPC2Ad7FZ56_MRT67c_agHPE4WhoR9wCtkiD7oeMT5FaKeYcne4AgJdDSvX_H9OGuTN20yHkL2rrTnOL0UJH1A504PCT6-nVfo-cft081d9fD48_7m-0NlWMtyxduWg-kb0E3rSKN1wwVrnOyFLFtaCY71XW8JJ7XUgjaSMeEIt5K5ztmmY1foy2lu-fjXAimr0ScDw6ADTEtSjMpWdLzYUdDPb-jSj2DVHMvG8aj-elSA-gSYOKUUwf1DKFFbEOqgtiDUFoQ6BVFE306iYhusHqL644YB6yOYrOzk_yf_DVWmkcY |
| Cites_doi | 10.1111/vec.12030 10.1111/jvp.12917 10.1007/s00109-020-01983-y 10.1038/nrneph.2013.109 10.1007/s11095-024-03689-z 10.1292/jvms.17-0620 10.3390/cells13141190 10.2460/ajvr.24.07.0212 10.2460/ajvr.2001.62.375 10.1080/17425255.2024.2311154 10.1038/s41580-020-0258-4 10.3390/ijms25020701 10.1016/j.ijpharm.2018.04.042 10.1016/S0009-9236(97)90160-0 10.1038/s41598-023-40160-2 10.1177/1098612X13495234 10.1177/1098612X211037872 10.1038/s41598-021-88154-2 10.1111/jvp.12473 10.3390/s23146301 10.1038/s41581-019-0176-x 10.1016/j.tvjl.2021.105626 10.1186/s12917-022-03323-3 10.1038/s41568-018-0007-6 10.1186/s12915-019-0652-6 10.1016/j.jcmgh.2021.04.010 10.3389/ti.2024.12468 10.1101/2022.07.15.500059 10.1038/nrneph.2017.52 10.1088/1758-5090/ad38df 10.2174/1570159X20666220830105350 10.1007/s11095-024-03766-3 10.2460/ajvr.23.04.0081 10.1111/jvim.12600 10.1016/S1561-5413(09)60109-5 10.1186/s42826-022-00128-1 10.1016/j.cell.2021.08.005 10.1111/jvim.13917 10.1208/s12248-017-0178-1 10.1016/j.cvsm.2016.06.009 10.1111/rda.12562 10.1177/1098612X231206125 10.24272/j.issn.2095-8137.2024.072 10.3390/s22239533 10.1016/j.pt.2019.10.013 10.1046/j.1365-2885.2000.00272.x 10.1007/s11095-024-03664-8 10.12968/vetn.2012.3.10.600 10.1186/s40164-023-00433-y 10.1371/journal.pmed.1000161 10.1038/s41576-022-00466-9 |
| ContentType | Journal Article |
| Copyright | 2025 The Authors Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved. Copyright © 2025. Published by Elsevier B.V. |
| Copyright_xml | – notice: 2025 The Authors – notice: Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved. – notice: Copyright © 2025. Published by Elsevier B.V. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ejps.2025.107111 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Veterinary Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1879-0720 |
| ExternalDocumentID | 40286991 10_1016_j_ejps_2025_107111 S0928098725001101 |
| Genre | Letter Journal Article Review Correspondence |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 6I. 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFTH AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABFRF ABJNI ABLJU ABMAC ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE ADPDF ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFTJW AFXIZ AGCQF AGHFR AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP AXJTR BKOJK BLXMC BNPGV C45 CS3 DU5 EBS EFJIC EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA GROUPED_DOAJ IHE J1W KOM MO0 N9A O-L O9- OAUVE OGGZJ OK1 OVD OZT P-8 P-9 P2P PC. Q38 RPZ SCC SDF SDG SDP SES SEW SPCBC SSH SSP SSZ T5K TEORI ~G- 29G 53G 5VS AAQXK AAYXX ABFNM ABWVN ABXDB ACRPL ADMUD ADNMO AGQPQ ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HMT HVGLF HZ~ M34 M41 R2- RIG ROL SPT WUQ CGR CUY CVF ECM EFKBS EIF NPM 7X8 EFLBG |
| ID | FETCH-LOGICAL-c353t-6556ecb4ea45f04aa46734f9b79111d9ef3b8bd06029a7149337f06d93f8fd483 |
| IEDL.DBID | AIKHN |
| ISSN | 0928-0987 1879-0720 |
| IngestDate | Fri Sep 05 17:24:13 EDT 2025 Mon Jul 21 05:34:54 EDT 2025 Sun Jul 06 05:04:23 EDT 2025 Sat Jun 28 18:17:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | 3Rs Organoids Veterinary medicine Alternative methods In silico modeling |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c353t-6556ecb4ea45f04aa46734f9b79111d9ef3b8bd06029a7149337f06d93f8fd483 |
| Notes | content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 |
| ORCID | 0000-0002-0997-3111 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0928098725001101 |
| PMID | 40286991 |
| PQID | 3195786687 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3195786687 pubmed_primary_40286991 crossref_primary_10_1016_j_ejps_2025_107111 elsevier_sciencedirect_doi_10_1016_j_ejps_2025_107111 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-07-01 |
| PublicationDateYYYYMMDD | 2025-07-01 |
| PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | European journal of pharmaceutical sciences |
| PublicationTitleAlternate | Eur J Pharm Sci |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Brown, Brown, Jacobs (bib0009) 2001; 62 CDC (2024). Chronic kidney disease in the United States, 2023. Available at Chandra, Borcherding, Kingsbury (bib0011) 2019; 17 Li, Ma, Qin (bib0034) 2023; 21 Zoccali, Vanholder, Massy (bib0064) 2017; 13 Cowgill, L. (2023). International renal interest society (IRIS). (2019). IRIS Staging of CKD (see link to 2023 pdf of modified criteria as provided on this website). Available at Sheiner (bib0050) 1997; 61 Nishinakamura (bib0041) 2019; 15 Toutain, Pelligand, Lees (bib0055) 2021; 44 Lawson, Jepson (bib0033) 2021; 23 Shankar, Tejeda-Mora, Du (bib0049) 2024; 37 Adiwidjaja, Spires, Brouwer (bib0001) 2024; 41 Billington, K. and Webb, T. (2024). Chronic kidney disease. Available at Baird, Barsby, Guest (bib0003) 2015; 50 Reynolds, Lefebvre (bib0045) 2013; 15 Breton (bib0007) 2012; 3 Agu, Afiukwa, Orji (bib0002) 2023; 13 [Accessed October 29, 2024]. [Accessed November 12, 2024]. Gupta, Dilmen, Morizane (bib0027) 2021; 99 Bijsmans, Jepson, Chang (bib0004) 2015; 29 Gabriel, Zdyrski, Sahoo (bib0025) 2024; 25 Brown (bib0008) 2013; 23 Finch, Syme, Elliott (bib0024) 2016; 30 Na, Cui, Fang (bib0040) 2024; 13 . Magalhães, Lourenço, Corbee (bib0035) 2023; 25 Schmiedt, Beita, Lourenço (bib0048) 2023 Cross, Martinez, M.N., Pade, D. et al. (2025). A bottom-up approach for mutant and wild type collies using physiologically-based pharmacokinetic (PBPK) modeling: a case study using Loperamide. (submitted). Hori, Heishima, Yamashita (bib0030) 2018; 80 Zamir, Alqahtani, Rasool (bib0062) 2024; 20 Timmerman, Macaire, Hanne-Poujade (bib0053) 2022; 22 Van De Water, Oosterlinck, Korthagen (bib0057) 2021; 270 Saura, Zamorano, Zaragoza (bib0047) 2022; 13 Han, Mslati, Davies (bib0028) 2021; 12 Drost, Clevers (bib0019) 2018; 18 CVM GFI #276. (2024). Effectiveness of anthelmintics: specific recommendations for products proposed for the prevention of heartworm disease in dogs. Available at Yamada, Do Prado Vendruscolo, Marsiglia (bib0061) 2022; 18 Mochel, Jergens, Kingsbury (bib0038) 2017; 20 Dong, Qu, Pavurala (bib0018) 2018; 544 systems to model cryptosporidium parvum infection in 2D and 3D Korwin-Mihavics, B.R., Dews, E.A., di Genova, B.M. et al. (2023). Organoid-based Helal, Martinez, Longstaff (bib0029) 2024; 41 Ingber (bib0031) 2022; 23 Oishi, Tabibzadeh, Morizane (bib0042) 2024; 16 Mukherjee, Roy, Ghosh (bib0039) 2022; 38 Suh, Miner (bib0052) 2013; 9 Duque-Correa, Maizels, Grencis (bib0020) 2020; 36 Crecan, Peștean (bib0015) 2023; 23 Quisenberry, Allenspach-Jorn, Mochel (bib0043) 2024; 85 Vunjak-Novakovic, Ronaldson-Bouchard, Radisic (bib0059) 2021; 184 Bon, Toutain, Concordet (bib0006) 2018; 41 Whittem, Hogan, Sisson (bib0060) 2000; 23 Gordon, Paoloni, Mazcko (bib0026) 2009; 6 Zdyrski, C., Gabriel, V., Ospina, O. et al. (2024). A multi-tissue comparison and molecular characterization of canine organoids. bioRxiv. 2022.07.15.500059 Vaden, Elliott (bib0056) 2016; 46 [Accessed February 2, 2025]. Martinez, Fahmy, Li (bib0036) 2024; 41 2023.09.29.560165. Toutain (bib0054) 2024 Fang, Li, Du (bib0022) 2023; 12 Miao, Zhu, Wang (bib0037) 2024; 45 FDA (2025). FDA artificial intelligence for drug development. Available at Russell, Burch (bib0046) 1992 VICH GL19. (2022). Effectiveness of anthelmintics: specific recommendations for canines. Available at Rasool, Ali, Khalid (bib0044) 2021; 11 Chow, Liu, Chang (bib0012) 2003; 5 Shi, Kowalczewski, Vu (bib0051) 2024; 21 EMA (2024). Ethical use of animals in medicine testing. Available at Clevers (bib0013) 2020; 21 Brown (10.1016/j.ejps.2025.107111_bib0008) 2013; 23 Rasool (10.1016/j.ejps.2025.107111_bib0044) 2021; 11 Bon (10.1016/j.ejps.2025.107111_bib0006) 2018; 41 Brown (10.1016/j.ejps.2025.107111_bib0009) 2001; 62 Gabriel (10.1016/j.ejps.2025.107111_bib0025) 2024; 25 Timmerman (10.1016/j.ejps.2025.107111_bib0053) 2022; 22 Quisenberry (10.1016/j.ejps.2025.107111_bib0043) 2024; 85 Toutain (10.1016/j.ejps.2025.107111_bib0054) 2024 Suh (10.1016/j.ejps.2025.107111_bib0052) 2013; 9 Toutain (10.1016/j.ejps.2025.107111_bib0055) 2021; 44 Bijsmans (10.1016/j.ejps.2025.107111_bib0004) 2015; 29 Mukherjee (10.1016/j.ejps.2025.107111_bib0039) 2022; 38 Duque-Correa (10.1016/j.ejps.2025.107111_bib0020) 2020; 36 Han (10.1016/j.ejps.2025.107111_bib0028) 2021; 12 Magalhães (10.1016/j.ejps.2025.107111_bib0035) 2023; 25 Russell (10.1016/j.ejps.2025.107111_bib0046) 1992 Miao (10.1016/j.ejps.2025.107111_bib0037) 2024; 45 Mochel (10.1016/j.ejps.2025.107111_bib0038) 2017; 20 Shi (10.1016/j.ejps.2025.107111_bib0051) 2024; 21 Schmiedt (10.1016/j.ejps.2025.107111_bib0048) 2023 Gupta (10.1016/j.ejps.2025.107111_bib0027) 2021; 99 10.1016/j.ejps.2025.107111_bib0032 Zoccali (10.1016/j.ejps.2025.107111_bib0064) 2017; 13 Hori (10.1016/j.ejps.2025.107111_bib0030) 2018; 80 Agu (10.1016/j.ejps.2025.107111_bib0002) 2023; 13 Clevers (10.1016/j.ejps.2025.107111_bib0013) 2020; 21 Adiwidjaja (10.1016/j.ejps.2025.107111_bib0001) 2024; 41 Baird (10.1016/j.ejps.2025.107111_bib0003) 2015; 50 Oishi (10.1016/j.ejps.2025.107111_bib0042) 2024; 16 Dong (10.1016/j.ejps.2025.107111_bib0018) 2018; 544 Yamada (10.1016/j.ejps.2025.107111_bib0061) 2022; 18 Crecan (10.1016/j.ejps.2025.107111_bib0015) 2023; 23 Fang (10.1016/j.ejps.2025.107111_bib0022) 2023; 12 10.1016/j.ejps.2025.107111_bib0017 Saura (10.1016/j.ejps.2025.107111_bib0047) 2022; 13 Van De Water (10.1016/j.ejps.2025.107111_bib0057) 2021; 270 Li (10.1016/j.ejps.2025.107111_bib0034) 2023; 21 10.1016/j.ejps.2025.107111_bib0016 Gordon (10.1016/j.ejps.2025.107111_bib0026) 2009; 6 Chow (10.1016/j.ejps.2025.107111_bib0012) 2003; 5 Reynolds (10.1016/j.ejps.2025.107111_bib0045) 2013; 15 Vunjak-Novakovic (10.1016/j.ejps.2025.107111_bib0059) 2021; 184 10.1016/j.ejps.2025.107111_bib0021 Breton (10.1016/j.ejps.2025.107111_bib0007) 2012; 3 Lawson (10.1016/j.ejps.2025.107111_bib0033) 2021; 23 10.1016/j.ejps.2025.107111_bib0063 Na (10.1016/j.ejps.2025.107111_bib0040) 2024; 13 10.1016/j.ejps.2025.107111_bib0023 Martinez (10.1016/j.ejps.2025.107111_bib0036) 2024; 41 Shankar (10.1016/j.ejps.2025.107111_bib0049) 2024; 37 Vaden (10.1016/j.ejps.2025.107111_bib0056) 2016; 46 Sheiner (10.1016/j.ejps.2025.107111_bib0050) 1997; 61 Ingber (10.1016/j.ejps.2025.107111_bib0031) 2022; 23 Finch (10.1016/j.ejps.2025.107111_bib0024) 2016; 30 Whittem (10.1016/j.ejps.2025.107111_bib0060) 2000; 23 Helal (10.1016/j.ejps.2025.107111_bib0029) 2024; 41 10.1016/j.ejps.2025.107111_bib0005 10.1016/j.ejps.2025.107111_bib0010 Chandra (10.1016/j.ejps.2025.107111_bib0011) 2019; 17 Drost (10.1016/j.ejps.2025.107111_bib0019) 2018; 18 Nishinakamura (10.1016/j.ejps.2025.107111_bib0041) 2019; 15 10.1016/j.ejps.2025.107111_bib0014 10.1016/j.ejps.2025.107111_bib0058 Zamir (10.1016/j.ejps.2025.107111_bib0062) 2024; 20 |
| References_xml | – volume: 62 start-page: 375 year: 2001 end-page: 383 ident: bib0009 article-title: Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency publication-title: ajvr – volume: 18 start-page: 215 year: 2022 ident: bib0061 article-title: Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses publication-title: BMC Vet. Res. – reference: Billington, K. and Webb, T. (2024). Chronic kidney disease. Available at: – volume: 41 start-page: 1007 year: 2024 end-page: 1020 ident: bib0029 article-title: Development and validation of matrix of chemistry, manufacturing, and control (MoCMC) system for intramammary drug products (IMM) publication-title: Pharm. Res. – volume: 9 start-page: 470 year: 2013 end-page: 477 ident: bib0052 article-title: The glomerular basement membrane as a barrier to albumin publication-title: Nat. Rev. Nephrol. – volume: 30 start-page: 602 year: 2016 end-page: 610 ident: bib0024 article-title: Risk factors for development of chronic kidney disease in cats publication-title: J. Vet. Intern. Med. – reference: FDA (2025). FDA artificial intelligence for drug development. Available at: – volume: 21 year: 2024 ident: bib0051 article-title: Organoid intelligence: integration of organoid technology and artificial intelligence in the new era of publication-title: Med. Nov. Technol. Dev. – volume: 270 year: 2021 ident: bib0057 article-title: The lipopolysaccharide model for the experimental induction of transient lameness and synovitis in Standardbred horses publication-title: Vet. J. – volume: 13 start-page: 344 year: 2017 end-page: 358 ident: bib0064 article-title: The systemic nature of CKD publication-title: Nat. Rev. Nephrol. – reference: , 2023.09.29.560165. – volume: 36 start-page: 170 year: 2020 end-page: 181 ident: bib0020 article-title: New models for host-helminth interactions publication-title: Trends Parasitol. – reference: [Accessed October 29, 2024]. – volume: 37 year: 2024 ident: bib0049 article-title: Interactions of the immune system with human kidney organoids publication-title: Transpl. Int. – year: 2024 ident: bib0054 article-title: Why the racing industry and equestrian disciplines need to implement population pharmacokinetics: to learn, explain, summarize, harmonize, and individualize publication-title: Drug Test. Anal. – volume: 18 start-page: 407 year: 2018 end-page: 418 ident: bib0019 article-title: Organoids in cancer research publication-title: Nat. Rev. Cancer – reference: [Accessed February 2, 2025]. – volume: 184 start-page: 4597 year: 2021 end-page: 4611 ident: bib0059 article-title: Organs-on-a-chip models for biological research publication-title: Cell – volume: 12 start-page: 69 year: 2023 ident: bib0022 article-title: The role of organoids in cancer research publication-title: Exp. Hematol. Oncol. – volume: 80 start-page: 447 year: 2018 end-page: 452 ident: bib0030 article-title: Relationship between indirect blood pressure and various stages of chronic kidney disease in cats publication-title: J. Vet. Med. Sci. – reference: Cowgill, L. (2023). International renal interest society (IRIS). (2019). IRIS Staging of CKD (see link to 2023 pdf of modified criteria as provided on this website). Available at: – reference: VICH GL19. (2022). Effectiveness of anthelmintics: specific recommendations for canines. Available at: – volume: 13 year: 2023 ident: bib0002 article-title: Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management publication-title: Sci. Rep. – volume: 544 start-page: 254 year: 2018 end-page: 264 ident: bib0018 article-title: Formulation characteristics and publication-title: Int. J. Pharm. – volume: 20 start-page: 95 year: 2024 end-page: 105 ident: bib0062 article-title: Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models publication-title: Expert. Opin. Drug Metab. Toxicol. – volume: 85 year: 2024 ident: bib0043 article-title: University of Georgia college of veterinary medicine’s precision one health initiative improves animal and human health by developing alternative models of disease publication-title: Am. J. Vet. Res. – volume: 23 start-page: 261 year: 2000 end-page: 263 ident: bib0060 article-title: The population pharmacokinetics of digoxin in dogs with heart disease publication-title: J. Vet. Pharmacol. Ther. – reference: systems to model cryptosporidium parvum infection in 2D and 3D – reference: Korwin-Mihavics, B.R., Dews, E.A., di Genova, B.M. et al. (2023). Organoid-based – start-page: 1 year: 2023 end-page: 11 ident: bib0048 article-title: A remnant kidney surgery model in cats induces acute and chronic outcomes that mimic spontaneous chronic kidney disease publication-title: ajvr – reference: CVM GFI #276. (2024). Effectiveness of anthelmintics: specific recommendations for products proposed for the prevention of heartworm disease in dogs. Available at: – volume: 21 start-page: 355 year: 2020 end-page: 356 ident: bib0013 article-title: COVID-19: organoids go viral publication-title: Nat. Rev. Mol. Cell Biol. – volume: 15 start-page: 613 year: 2019 end-page: 624 ident: bib0041 article-title: Human kidney organoids: progress and remaining challenges publication-title: Nat. Rev. Nephrol. – volume: 11 start-page: 8589 year: 2021 ident: bib0044 article-title: Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases publication-title: Sci. Rep. – volume: 3 start-page: 600 year: 2012 end-page: 607 ident: bib0007 article-title: Pathophysiology and treatment of kidney disease in cats publication-title: Vet. Nurse – volume: 38 start-page: 18 year: 2022 ident: bib0039 article-title: Role of animal models in biomedical research: a review publication-title: Lab. Anim. Res. – volume: 23 start-page: 115 year: 2013 end-page: 121 ident: bib0008 article-title: Renal pathophysiology: lessons learned from the canine remnant kidney model publication-title: J. Vet. Emerg. Crit. Care – volume: 21 start-page: 2447 year: 2023 end-page: 2464 ident: bib0034 article-title: Virtual screening-based drug development for the treatment of nervous system diseases publication-title: CN – volume: 29 start-page: 855 year: 2015 end-page: 861 ident: bib0004 article-title: Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease publication-title: J. Vet. Intern. Med. – volume: 17 start-page: 33 year: 2019 ident: bib0011 article-title: Derivation of adult canine intestinal organoids for translational research in gastroenterology publication-title: BMC Biol. – volume: 13 start-page: 1190 year: 2024 ident: bib0040 article-title: Advancements in research on genetic kidney diseases using human-induced pluripotent stem cell-derived kidney organoids publication-title: Cells – reference: [Accessed November 12, 2024]. – volume: 25 year: 2023 ident: bib0035 article-title: Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study publication-title: J. Feline Med. Surg. – volume: 15 start-page: 3 year: 2013 end-page: 14 ident: bib0045 article-title: Feline CKD: pathophysiology and risk factors–what do we know? publication-title: J. Feline Med. Surg. – volume: 12 start-page: 769 year: 2021 end-page: 782 ident: bib0028 article-title: Creating a more perfect union: modeling intestinal bacteria-epithelial interactions using organoids publication-title: Cell Mol. Gastroenterol. Hepatol. – volume: 13 year: 2022 ident: bib0047 article-title: Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice publication-title: Front. Physiol. – reference: Zdyrski, C., Gabriel, V., Ospina, O. et al. (2024). A multi-tissue comparison and molecular characterization of canine organoids. bioRxiv. 2022.07.15.500059; – volume: 25 start-page: 701 year: 2024 ident: bib0025 article-title: Adult animal stem cell-derived organoids in biomedical research and the one health paradigm publication-title: Int. J. Mol. Sci. – reference: CDC (2024). Chronic kidney disease in the United States, 2023. Available at: – reference: [Accessed November 12, 2024]. – volume: 5 start-page: 57 year: 2003 end-page: 64 ident: bib0012 article-title: Animal remnant kidney model of chronic renal failure revisited publication-title: Hong Kong J. Nephrol. – reference: Cross, Martinez, M.N., Pade, D. et al. (2025). A bottom-up approach for mutant and wild type collies using physiologically-based pharmacokinetic (PBPK) modeling: a case study using Loperamide. (submitted). – volume: 23 start-page: 6301 year: 2023 ident: bib0015 article-title: Inertial sensor technologies—their role in equine gait analysis, a review publication-title: Sensors – reference: . – reference: EMA (2024). Ethical use of animals in medicine testing. Available at: – volume: 6 year: 2009 ident: bib0026 article-title: The comparative oncology trials consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway publication-title: PLoS Med. – volume: 22 start-page: 9533 year: 2022 ident: bib0053 article-title: A pilot study on the inter-operator reproducibility of a wireless sensors-based system for quantifying gait asymmetries in horses publication-title: Sensors – volume: 45 start-page: 1161 year: 2024 end-page: 1174 ident: bib0037 article-title: Experimental models for preclinical research in kidney disease publication-title: Zool. Res. – volume: 46 start-page: 1115 year: 2016 end-page: 1130 ident: bib0056 article-title: Management of proteinuria in dogs and cats with chronic kidney disease publication-title: Vet. Clin. North Am. Small. Anim. Pract. – volume: 41 start-page: 171 year: 2018 end-page: 183 ident: bib0006 article-title: Mathematical modeling and simulation in animal health. Part publication-title: Vet. Pharm. Therap. – volume: 61 start-page: 275 year: 1997 end-page: 291 ident: bib0050 article-title: Learning publication-title: Clin. Pharmacol. Ther. – volume: 99 start-page: 477 year: 2021 end-page: 487 ident: bib0027 article-title: 3D kidney organoids for bench-to-bedside translation publication-title: J. Mol. Med. (Berl) – volume: 20 start-page: 17 year: 2017 ident: bib0038 article-title: Intestinal stem cells to advance drug development, precision, and regenerative medicine: a paradigm shift in translational research publication-title: AAPS J. – volume: 41 start-page: 441 year: 2024 end-page: 462 ident: bib0001 article-title: Physiologically based pharmacokinetic (PBPK) model predictions of disease mediated changes in drug disposition in patients with nonalcoholic fatty liver disease (NAFLD) publication-title: Pharm. Res. – volume: 23 start-page: 467 year: 2022 end-page: 491 ident: bib0031 article-title: Human organs-on-chips for disease modelling, drug development and personalized medicine publication-title: Nat. Rev. Genet. – year: 1992 ident: bib0046 article-title: The Principles of Humane Experimental Technique – volume: 41 start-page: 1797 year: 2024 end-page: 1809 ident: bib0036 article-title: The use of systemically absorbed drugs to explore an publication-title: Pharm. Res. – volume: 23 start-page: 812 year: 2021 end-page: 822 ident: bib0033 article-title: Feline comorbidities: the intermingled relationship between chronic kidney disease and hypertension publication-title: J. Feline Med. Surg. – volume: 50 start-page: 669 year: 2015 end-page: 676 ident: bib0003 article-title: Derivation of canine induced pluripotent stem cells publication-title: Reprod. Domest. Anim. – volume: 44 start-page: 172 year: 2021 end-page: 200 ident: bib0055 article-title: The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: recent advances and critical appraisal publication-title: J. Vet. Pharmacol. Ther. – volume: 16 year: 2024 ident: bib0042 article-title: Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids publication-title: Biofabrication – volume: 23 start-page: 115 year: 2013 ident: 10.1016/j.ejps.2025.107111_bib0008 article-title: Renal pathophysiology: lessons learned from the canine remnant kidney model publication-title: J. Vet. Emerg. Crit. Care doi: 10.1111/vec.12030 – ident: 10.1016/j.ejps.2025.107111_bib0010 – volume: 44 start-page: 172 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0055 article-title: The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: recent advances and critical appraisal publication-title: J. Vet. Pharmacol. Ther. doi: 10.1111/jvp.12917 – volume: 99 start-page: 477 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0027 article-title: 3D kidney organoids for bench-to-bedside translation publication-title: J. Mol. Med. (Berl) doi: 10.1007/s00109-020-01983-y – volume: 9 start-page: 470 year: 2013 ident: 10.1016/j.ejps.2025.107111_bib0052 article-title: The glomerular basement membrane as a barrier to albumin publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2013.109 – volume: 41 start-page: 1007 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0029 article-title: Development and validation of matrix of chemistry, manufacturing, and control (MoCMC) system for intramammary drug products (IMM) publication-title: Pharm. Res. doi: 10.1007/s11095-024-03689-z – volume: 80 start-page: 447 year: 2018 ident: 10.1016/j.ejps.2025.107111_bib0030 article-title: Relationship between indirect blood pressure and various stages of chronic kidney disease in cats publication-title: J. Vet. Med. Sci. doi: 10.1292/jvms.17-0620 – year: 1992 ident: 10.1016/j.ejps.2025.107111_bib0046 – volume: 13 start-page: 1190 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0040 article-title: Advancements in research on genetic kidney diseases using human-induced pluripotent stem cell-derived kidney organoids publication-title: Cells doi: 10.3390/cells13141190 – ident: 10.1016/j.ejps.2025.107111_bib0023 – volume: 85 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0043 article-title: University of Georgia college of veterinary medicine’s precision one health initiative improves animal and human health by developing alternative models of disease publication-title: Am. J. Vet. Res. doi: 10.2460/ajvr.24.07.0212 – volume: 62 start-page: 375 year: 2001 ident: 10.1016/j.ejps.2025.107111_bib0009 article-title: Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency publication-title: ajvr doi: 10.2460/ajvr.2001.62.375 – volume: 20 start-page: 95 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0062 article-title: Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models publication-title: Expert. Opin. Drug Metab. Toxicol. doi: 10.1080/17425255.2024.2311154 – volume: 21 start-page: 355 year: 2020 ident: 10.1016/j.ejps.2025.107111_bib0013 article-title: COVID-19: organoids go viral publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-020-0258-4 – ident: 10.1016/j.ejps.2025.107111_bib0014 – volume: 25 start-page: 701 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0025 article-title: Adult animal stem cell-derived organoids in biomedical research and the one health paradigm publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms25020701 – volume: 544 start-page: 254 year: 2018 ident: 10.1016/j.ejps.2025.107111_bib0018 article-title: Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2018.04.042 – volume: 61 start-page: 275 year: 1997 ident: 10.1016/j.ejps.2025.107111_bib0050 article-title: Learning versus confirming in clinical drug development publication-title: Clin. Pharmacol. Ther. doi: 10.1016/S0009-9236(97)90160-0 – volume: 13 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0002 article-title: Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management publication-title: Sci. Rep. doi: 10.1038/s41598-023-40160-2 – volume: 15 start-page: 3 issue: Suppl 1 year: 2013 ident: 10.1016/j.ejps.2025.107111_bib0045 article-title: Feline CKD: pathophysiology and risk factors–what do we know? publication-title: J. Feline Med. Surg. doi: 10.1177/1098612X13495234 – volume: 23 start-page: 812 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0033 article-title: Feline comorbidities: the intermingled relationship between chronic kidney disease and hypertension publication-title: J. Feline Med. Surg. doi: 10.1177/1098612X211037872 – volume: 11 start-page: 8589 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0044 article-title: Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases publication-title: Sci. Rep. doi: 10.1038/s41598-021-88154-2 – ident: 10.1016/j.ejps.2025.107111_bib0005 – volume: 41 start-page: 171 year: 2018 ident: 10.1016/j.ejps.2025.107111_bib0006 article-title: Mathematical modeling and simulation in animal health. Part III : using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics publication-title: Vet. Pharm. Therap. doi: 10.1111/jvp.12473 – volume: 23 start-page: 6301 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0015 article-title: Inertial sensor technologies—their role in equine gait analysis, a review publication-title: Sensors doi: 10.3390/s23146301 – volume: 15 start-page: 613 year: 2019 ident: 10.1016/j.ejps.2025.107111_bib0041 article-title: Human kidney organoids: progress and remaining challenges publication-title: Nat. Rev. Nephrol. doi: 10.1038/s41581-019-0176-x – volume: 270 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0057 article-title: The lipopolysaccharide model for the experimental induction of transient lameness and synovitis in Standardbred horses publication-title: Vet. J. doi: 10.1016/j.tvjl.2021.105626 – volume: 18 start-page: 215 year: 2022 ident: 10.1016/j.ejps.2025.107111_bib0061 article-title: Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses publication-title: BMC Vet. Res. doi: 10.1186/s12917-022-03323-3 – volume: 13 year: 2022 ident: 10.1016/j.ejps.2025.107111_bib0047 article-title: Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice publication-title: Front. Physiol. – volume: 18 start-page: 407 year: 2018 ident: 10.1016/j.ejps.2025.107111_bib0019 article-title: Organoids in cancer research publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-018-0007-6 – ident: 10.1016/j.ejps.2025.107111_bib0032 – volume: 17 start-page: 33 year: 2019 ident: 10.1016/j.ejps.2025.107111_bib0011 article-title: Derivation of adult canine intestinal organoids for translational research in gastroenterology publication-title: BMC Biol. doi: 10.1186/s12915-019-0652-6 – volume: 12 start-page: 769 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0028 article-title: Creating a more perfect union: modeling intestinal bacteria-epithelial interactions using organoids publication-title: Cell Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2021.04.010 – ident: 10.1016/j.ejps.2025.107111_bib0058 – volume: 37 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0049 article-title: Interactions of the immune system with human kidney organoids publication-title: Transpl. Int. doi: 10.3389/ti.2024.12468 – year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0054 article-title: Why the racing industry and equestrian disciplines need to implement population pharmacokinetics: to learn, explain, summarize, harmonize, and individualize publication-title: Drug Test. Anal. – ident: 10.1016/j.ejps.2025.107111_bib0063 doi: 10.1101/2022.07.15.500059 – ident: 10.1016/j.ejps.2025.107111_bib0021 – volume: 13 start-page: 344 year: 2017 ident: 10.1016/j.ejps.2025.107111_bib0064 article-title: The systemic nature of CKD publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2017.52 – volume: 16 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0042 article-title: Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids publication-title: Biofabrication doi: 10.1088/1758-5090/ad38df – ident: 10.1016/j.ejps.2025.107111_bib0016 – volume: 21 start-page: 2447 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0034 article-title: Virtual screening-based drug development for the treatment of nervous system diseases publication-title: CN doi: 10.2174/1570159X20666220830105350 – volume: 41 start-page: 1797 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0036 article-title: The use of systemically absorbed drugs to explore an in vitro bioequivalence approach for comparing non-systemically absorbed active pharmaceutical ingredients in drug products for use in dogs publication-title: Pharm. Res. doi: 10.1007/s11095-024-03766-3 – start-page: 1 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0048 article-title: A remnant kidney surgery model in cats induces acute and chronic outcomes that mimic spontaneous chronic kidney disease publication-title: ajvr doi: 10.2460/ajvr.23.04.0081 – volume: 29 start-page: 855 year: 2015 ident: 10.1016/j.ejps.2025.107111_bib0004 article-title: Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease publication-title: J. Vet. Intern. Med. doi: 10.1111/jvim.12600 – volume: 5 start-page: 57 year: 2003 ident: 10.1016/j.ejps.2025.107111_bib0012 article-title: Animal remnant kidney model of chronic renal failure revisited publication-title: Hong Kong J. Nephrol. doi: 10.1016/S1561-5413(09)60109-5 – volume: 38 start-page: 18 year: 2022 ident: 10.1016/j.ejps.2025.107111_bib0039 article-title: Role of animal models in biomedical research: a review publication-title: Lab. Anim. Res. doi: 10.1186/s42826-022-00128-1 – volume: 184 start-page: 4597 year: 2021 ident: 10.1016/j.ejps.2025.107111_bib0059 article-title: Organs-on-a-chip models for biological research publication-title: Cell doi: 10.1016/j.cell.2021.08.005 – volume: 30 start-page: 602 year: 2016 ident: 10.1016/j.ejps.2025.107111_bib0024 article-title: Risk factors for development of chronic kidney disease in cats publication-title: J. Vet. Intern. Med. doi: 10.1111/jvim.13917 – volume: 21 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0051 article-title: Organoid intelligence: integration of organoid technology and artificial intelligence in the new era of in vitro models publication-title: Med. Nov. Technol. Dev. – volume: 20 start-page: 17 year: 2017 ident: 10.1016/j.ejps.2025.107111_bib0038 article-title: Intestinal stem cells to advance drug development, precision, and regenerative medicine: a paradigm shift in translational research publication-title: AAPS J. doi: 10.1208/s12248-017-0178-1 – volume: 46 start-page: 1115 year: 2016 ident: 10.1016/j.ejps.2025.107111_bib0056 article-title: Management of proteinuria in dogs and cats with chronic kidney disease publication-title: Vet. Clin. North Am. Small. Anim. Pract. doi: 10.1016/j.cvsm.2016.06.009 – volume: 50 start-page: 669 year: 2015 ident: 10.1016/j.ejps.2025.107111_bib0003 article-title: Derivation of canine induced pluripotent stem cells publication-title: Reprod. Domest. Anim. doi: 10.1111/rda.12562 – volume: 25 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0035 article-title: Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study publication-title: J. Feline Med. Surg. doi: 10.1177/1098612X231206125 – volume: 45 start-page: 1161 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0037 article-title: Experimental models for preclinical research in kidney disease publication-title: Zool. Res. doi: 10.24272/j.issn.2095-8137.2024.072 – volume: 22 start-page: 9533 year: 2022 ident: 10.1016/j.ejps.2025.107111_bib0053 article-title: A pilot study on the inter-operator reproducibility of a wireless sensors-based system for quantifying gait asymmetries in horses publication-title: Sensors doi: 10.3390/s22239533 – volume: 36 start-page: 170 issue: 2 year: 2020 ident: 10.1016/j.ejps.2025.107111_bib0020 article-title: New models for host-helminth interactions publication-title: Trends Parasitol. doi: 10.1016/j.pt.2019.10.013 – volume: 23 start-page: 261 year: 2000 ident: 10.1016/j.ejps.2025.107111_bib0060 article-title: The population pharmacokinetics of digoxin in dogs with heart disease publication-title: J. Vet. Pharmacol. Ther. doi: 10.1046/j.1365-2885.2000.00272.x – volume: 41 start-page: 441 year: 2024 ident: 10.1016/j.ejps.2025.107111_bib0001 article-title: Physiologically based pharmacokinetic (PBPK) model predictions of disease mediated changes in drug disposition in patients with nonalcoholic fatty liver disease (NAFLD) publication-title: Pharm. Res. doi: 10.1007/s11095-024-03664-8 – volume: 3 start-page: 600 year: 2012 ident: 10.1016/j.ejps.2025.107111_bib0007 article-title: Pathophysiology and treatment of kidney disease in cats publication-title: Vet. Nurse doi: 10.12968/vetn.2012.3.10.600 – volume: 12 start-page: 69 year: 2023 ident: 10.1016/j.ejps.2025.107111_bib0022 article-title: The role of organoids in cancer research publication-title: Exp. Hematol. Oncol. doi: 10.1186/s40164-023-00433-y – volume: 6 year: 2009 ident: 10.1016/j.ejps.2025.107111_bib0026 article-title: The comparative oncology trials consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway publication-title: PLoS Med. doi: 10.1371/journal.pmed.1000161 – volume: 23 start-page: 467 year: 2022 ident: 10.1016/j.ejps.2025.107111_bib0031 article-title: Human organs-on-chips for disease modelling, drug development and personalized medicine publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-022-00466-9 – ident: 10.1016/j.ejps.2025.107111_bib0017 |
| SSID | ssj0006870 |
| Score | 2.454522 |
| SecondaryResourceType | review_article |
| Snippet | In veterinary medicine, experimental in vivo animal models have long been integral to advancing our understanding of disease mechanisms and assessing the... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 107111 |
| SubjectTerms | 3Rs Alternative methods Animal Testing Alternatives Animal Welfare Animals Disease Models, Animal Humans In silico modeling Models, Animal Organoids Veterinary medicine Veterinary Medicine - methods |
| Title | Evolving value and validity of animal models in veterinary therapeutic research: Impact of scientific progress |
| URI | https://dx.doi.org/10.1016/j.ejps.2025.107111 https://www.ncbi.nlm.nih.gov/pubmed/40286991 https://www.proquest.com/docview/3195786687 |
| Volume | 210 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELbocumlgu1rga5cqeJS0k3iR-zeEAItrUBIhYqb5cSOCBLZFbsgcelv70zssOUAh95iK44tj_PNjD3fmJAvvpK55UWViCq3CXdKJ6V1KimrrCpKsDe0R4LzyamcXvAfl-JyjRz0XBgMq4zYHzC9Q-tYM4mzOZk3zeRXqnOVgssMShyVGLhA6znTUgzI-v7xz-npIyBL1d0Zh-8n2CByZ0KYl7-eY9buXEBFkWXZc_rpOfuz00NHG-RNNCDpfhjjJlnz7ZDsnoUM1A979HxFqFrs0V16tspN_TAkw98Y_tJxcOlJPFZ_S9pDACncWaCY-9tT2zp8ahyY6HRWQ7m5gT67W3MWtGnp_eor_xC4aMwcdPWdHnfkS2wbGJcYkES7WDBA1nfk4ujw_GCaxIsYkooJtkykENJXJfeWizrl1gK6Ml7rskCodCBOVqrSpTLNtS3A52KsqFPpNKtV7bhi78mgnbX-I1LEwR90yiolcu5haTCnNVg5wjkBno4cka_99Jt5yLdh-kC0a4PCMigsE4Q1IqKXkHmyagwohBfbfe7FaeB3wjMS2_rZ3cIAIgGGSVgyI_IhyPlxHOBqKwn29NZ_9rpNXmMpBPvukMHy9s5_ApNmWY7Jq29_snFcuONuY-AvgfP3hA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF6hcGgvFaSv0AJbqeLSuHG8D6-5oShRaBOERFLltlp716qR6kRNqMSF386M1yZwgENvfqy91s76mxn7-2YJ-eoyGRkeZ4HIIhNwq5IgNVYFadbP4hTijcShwHl6Icdz_mMhFjtk0GhhkFZZY7_H9Aqt6yO9ejR7q6LoXYVJpEJImcGJoxODFGiXCxYjr-_73ZbnIVW1Yhy2DrB5rZzxJC93vcKa3ZGAA3G_33_OOz0XfVZeaLRH3tThIz3zT7hPdlzZJieXvv70bZfOtnKqdZee0MttZerbNmn_QvJLpcCl0_qn-ltSDgGi8LsCxcrfjprS4lZhIUCnyxz2iz_QZ7VmzpoWJf23vcsj-Rat6wb9PqXnlfQSr_V6S6Qj0YoJBrj6jsxHw9lgHNTLMAQZE2wTSCGky1LuDBd5yI0BbGU8T9IYgdKCMVmqUhvKMEpMDBkXY3EeSpuwXOWWK_aetMpl6T6iQByyQauMUiLiDiYGs0kCMY6wVkCeIzvkWzP8euWrbeiGhnat0VgajaW9sTpENBbST-aMBnfw4nVfGnNqeJnwD4kp3fJmrQGPAMEkTJkO-eDt_PAckGgrCdH0wX_2ekxejWfTiZ6cX_z8RF7jGU_7_Uxam7837hCCm016VE3ee83s91o |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evolving+value+and+validity+of+animal+models+in+veterinary+therapeutic+research%3A+Impact+of+scientific+progress&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Martinez%2C+Marilyn+N.&rft.au=Mochel%2C+Jonathan+P.&rft.au=Toutain%2C+Pierre-Louis&rft.date=2025-07-01&rft.issn=0928-0987&rft.volume=210&rft.spage=107111&rft_id=info:doi/10.1016%2Fj.ejps.2025.107111&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejps_2025_107111 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon |